G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $100,714 | -50.2% | 37,580 | +0.9% | 0.00% | – |
Q4 2022 | $202,153 | -37.4% | 37,229 | -12.5% | 0.00% | – |
Q1 2022 | $323,000 | -31.6% | 42,532 | -8.0% | 0.00% | -100.0% |
Q4 2021 | $472,000 | -22.4% | 46,224 | +2.0% | 0.00% | 0.0% |
Q3 2021 | $608,000 | -48.7% | 45,319 | -16.2% | 0.00% | 0.0% |
Q2 2021 | $1,186,000 | -4.2% | 54,050 | +5.1% | 0.00% | -50.0% |
Q1 2021 | $1,238,000 | +33.5% | 51,437 | -0.2% | 0.00% | +100.0% |
Q4 2020 | $927,000 | +55.8% | 51,552 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $595,000 | -52.0% | 51,552 | +0.9% | 0.00% | -50.0% |
Q2 2020 | $1,240,000 | +120.2% | 51,103 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $563,000 | -58.8% | 51,103 | -1.1% | 0.00% | -50.0% |
Q4 2019 | $1,366,000 | +13.6% | 51,680 | -2.1% | 0.00% | 0.0% |
Q3 2019 | $1,202,000 | -24.7% | 52,765 | +1.3% | 0.00% | -33.3% |
Q2 2019 | $1,597,000 | +169.8% | 52,094 | +46.0% | 0.00% | +200.0% |
Q1 2019 | $592,000 | -13.3% | 35,670 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $683,000 | -59.0% | 35,670 | +11.9% | 0.00% | -33.3% |
Q3 2018 | $1,667,000 | +22.8% | 31,885 | +2.1% | 0.00% | 0.0% |
Q2 2018 | $1,357,000 | +78.1% | 31,227 | +51.8% | 0.00% | +50.0% |
Q1 2018 | $762,000 | +207.3% | 20,576 | +64.6% | 0.00% | +100.0% |
Q4 2017 | $248,000 | -22.3% | 12,500 | -2.3% | 0.00% | 0.0% |
Q3 2017 | $319,000 | – | 12,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |